Loading company…
SIRS-Lab develops molecular diagnostic products to identify and monitor sepsis and severe infections.
Founded in 2000 and based in Germany, SIRS-Lab is a molecular diagnostics company. It develops products to identify and monitor sepsis and life-threatening infections.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in